featured
Bortezomib and Thalidomide Maintenance After Stem Cell Transplantation for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bortezomib and Thalidomide Maintenance After Stem Cell Transplantation for Multiple Myeloma: A PETHEMA/GEM Trial
Leukemia 2017 Feb 14;[EPub Ahead of Print], L Rosiñol, A Oriol, AI Teruel, AL de la Guía, M Blanchard, J de la Rubia, M Granell, M Sampol, L Palomera, Y González, M Etxebeste, R Martínez-Martínez, MT Hernández, F de Arriba, A Alegre, M Cibeira, M Mateos, J Martínez-López, JJ Lahuerta, J San Miguel, J BladéFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.